Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1516 of 6351
-
Ancient herbs take on superbug pneumonia in new clinical trial
Disease control Recruiting nowThis study aims to evaluate the clinical efficacy of a traditional Chinese medicine formula granule (Feireqing Granules) in the treatment of severe pneumonia caused by multidrug-resistant Gram-negative bacterial infections (MDR-GNB severe pneumonia), to establish a therapeutic re…
Sponsor: Henan University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Magic mushroom microdoses could lift Treatment-Resistant depression
Symptom relief Recruiting nowObjective: To assess the safety and efficacy of a six-week microdosing regimen of psilocybin combined with short-term, experience-based psychotherapy in patients with treatment-resistant depression who have not responded to previous pharmacological or long-term psychological int…
Phase 2 • Sponsor: Beersheva Mental Health Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Glue injection could seal pancreas after cancer surgery
Disease control Recruiting nowThis randomized controlled trial investigates the safety and efficacy of injecting N-butyl-2- cyanoacrylate (Histoacryl®) into the pancreatic parenchyma during pancreaticoduodenectomy (PD) to enhance the security of the pancreaticojejunostomy (PJ) anastomosis and reduce postopera…
Phase 2 • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New digital program aims to tame bipolar mood swings
Disease control Recruiting nowPEDAL is a group-based intervention for patients with bipolar disorder that builds on the traditional group psychoeducational program (GPP) by adding digital tools and specific strategies to help manage rapid fluctuations between affective states, known as affective lability. The…
Phase 2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for advanced prostate cancer: combination therapy enters human trials
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety of the combination therapy of Lutetium (177Lu) DGUL and pembrolizumab. It will also assess the antitumor efficacy and pharmacokinetics of the combination therapy compared to Lutetium (177Lu) DGUL monotherapy. Participants…
Phase 1 • Sponsor: Cellbion Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Heart failure drug finerenone faces major test in heart remodeling trial
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the drug finerenone (Karendia) can improve heart function in participants who are at risk for heart and kidney disease. The main question it aims to answer is whether adding finerenone to standard-of-care heart failure medical thera…
Phase 3 • Sponsor: Subodh Verma • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Mushroom-Derived compound joins forces with radiation and immunotherapy to fight advanced cancers
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a combination treatment using PRaG-1 Cordycepin Tablets with radiation therapy, immune-boosting injections, and immunotherapy drugs can help patients with advanced solid tumors. It will also assess safety. The main questions it aims …
Phase 2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug aims to tame rare, Exercise-Triggered heart condition
Disease control Recruiting nowThis is a Phase 2, multicenter, double-blind, sponsor blinded, placebo-controlled, repeat-dose clinical study of CRD-4730 to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CRD-4730 to participants with Catecholaminergic Polymorphic Ventricu…
Phase 2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Sound waves vs. seizures: new ultrasound treatment for epilepsy
Disease control Not yet recruitingThe study "Safety and Efficacy Evaluation of MR-Guided Focused Ultrasound Anterior Thalamic Nucleus Ablation for Drug-Resistant Epilepsy" from Chinese PLA General Hospital, is a single-center, prospective, single-arm study. It uses a MR-guided Focused Ultrasound Therapy System an…
Phase 1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can vitamin B12 restore your voice after thyroid surgery? new trial aims to find out
Symptom relief Not yet recruitingRecurrent laryngeal nerve injury is one of the most common and serious complications affecting quality of life after thyroid surgery. Intraoperative traction, clamping, thermal injury, or direct transection can lead to its dysfunction. Unilateral injury causes vocal cord paralysi…
Phase 3 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Light therapy may stop painful mouth sores in transplant patients
Prevention OngoingThe goal of this clinical trial is to learn if photobiomodulation works to prevent severe oral mucositis in patients who are undergoing allogeneic hematopoietic cell transplantation. The main questions it aims to answer are: Does 1) intraoral , 2) extraoral, or 3) combined intra…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC
-
Spit test could spot gum disease before It's too late
Diagnosis Not yet recruitingThis observational study aims to develop and validate a novel, AI-assisted electrochemical sensor platform for saliva-based diagnostics in periodontitis. Periodontitis is a chronic inflammatory disease affecting the gums and supporting tissues of the teeth. Despite its high globa…
Sponsor: Ostergotland County Council, Sweden • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
CBD oil put to the test for breast cancer joint pain
Symptom relief Not yet recruitingPhase III, single-center, randomized, double-blind, placebo-controlled, 2x2 cross- over study, assessing the efficacy of CBD in patients with early HR+ BC, presenting aromatase inhibitor-related musculoskeletal pain
Phase 3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis clinical trial is a prospective, dose-escalation, multicenter, single- arm, Phase 1 clinical trial to evaluate the safety, tolerability, PK and preliminary clinical activity of PRAME Antigen-targeted TCR-T Cells (NW-101C) infusion in patients with previously heavily treated,…
Phase 1 • Sponsor: Neowise Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Bone drug may shield cancer survivors from crippling fractures
Prevention Not yet recruitingPrimary Objective \- Proof of concept: To evaluate the efficacy of alendronate in preventing pelvic insufficiency fractures (PIFs) in cervical cancer patients treated with chemo-radiotherapy over the short and long term. This objective will assess both the immediate and sustaine…
Phase 1/2 • Sponsor: Dr. Itay GoorAryeh • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
New gene therapy trial hopes to tame advanced cancers
Disease control Not yet recruitingThis is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.
Phase 1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New cocktail of drugs aims to shrink Hard-to-Treat abdominal tumors
Disease control Not yet recruitingAssuming that the objective response rate (ORR) of neoadjuvant chemotherapy in patients with colorectal cancer peritoneal metastasis is approximately 0.40 , a total sample size of 30 patients is required. Step 1: Ten patients will be initially enrolled. If the number of respond…
Phase 2 • Sponsor: Guoxiang Cai • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New bead therapy may improve liver cancer treatment after shunt procedure
Disease control Recruiting nowThis is a Phase 3, open-label, multicenter, randomized controlled clinical trial designed to evaluate the efficacy and safety of Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) compared with Conventional Transarterial Chemoembolization (cTACE) in patients with hepato…
Phase 3 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug cocktail aims to shrink tough lung cancers
Disease control Not yet recruitingIn this single-arm, phase II study, we aimed to evaluate the efficacy and safety of sac-TMT plus bevacizumab in patients with advanced non-squamous NSCLC who showed disease progression on or after first-line ICI plus platinum-based chemotherapy.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New pill combo offers hope for Hard-to-Treat esophageal cancer
Disease control Recruiting nowThis study aims to investigate the safety and efficacy of oral paclitaxel combined with radiotherapy in the treatment of locally advanced unresectable esophageal squamous cell carcinoma.
Phase 2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC